AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 28985268
Drug: Intensive treatment
RxNorm normalized name: Head & Shoulders Intensive Treatment
DrugBank: Selenium Sulfide (DB00971)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive treatment (targeting SBP ≤ 120 mm Hg)
Trial: 28985268
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment (targeting SBP ≤ 140 mm Hg)
Trial: 8723308
Drug: Oral paroxetine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral paroxetine
Trial: 1806624
Drug: mianserin (60‐90
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mianserin (60‐90 mg/day)
Trial: 6308685
Drug: Captopril (CAP)
RxNorm normalized name: Captopril
DrugBank: Captopril (DB01197)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Captopril (CAP) 25 mg t.i.d. alone
Trial: 6308685
Drug: Captopril (CAP)
RxNorm normalized name: Captopril
DrugBank: Captopril (DB01197)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Captopril (CAP) 25 mg t.i.d. with hydrochlorothiazide (HCTZ) 50 mg/day
Trial: 6308685
Drug: Enalapril (ENA)
DrugBank: Enalapril (DB00584)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Enalapril (ENA) 5 or 10 mg/day
Trial: 31988226
Drug: Referral to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Referral to a commercial weight management programme plus stop smoking support (treatment group)
Trial: 28403408
Drug: Lidocaine (i.v.‐bolus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine (i.v.‐bolus injection of 1.5 mg kg ‐1 at induction of anaesthesia, followed by an infusion of 1.5 mg kg ‐1 h ‐1 until six h after arrival at the post‐anaesthesia care unit)
Trial: 25171056
Drug: 5,6-DMB supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5,6-DMB supplement (1.5 g daily)
Trial: 20953883
Drug: No supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No supplement (Control)
Trial: 23535096
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human C1 inhibitor (rhC1INH) 50-U/kg intravenous dose
Trial: 23535096
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human C1 inhibitor (rhC1INH) repeated treatment
Trial: 18829443
Drug: Korean hand
RxNorm normalized name: Korean ginseng root
DrugBank: Ginseng (DB01404)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Korean hand acupuncture therapy (HAT), 10 sessions
Trial: 18829443
Drug: Hand moxibustion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hand moxibustion therapy (HMT), 10 sessions
Trial: 16505133
Drug: 1.0 to
RxNorm normalized name: Pre Milk Iod 1.0 Topical Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 to 1.5 mg risperidone per day
Trial: 14989395
Drug: Fexofenadine, 180
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fexofenadine, 180 mg once daily (10 PM)
Trial: 14989395
Drug: Butterbur, 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Butterbur, 50 mg twice daily (8 AM and 10 PM)
Trial: 14989395
Drug: Montelukast, 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Montelukast, 10 mg once daily (10 PM)
Trial: 11381380
Drug: Arthrocentesis plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Arthrocentesis plus intra-articular injection of sodium hyaluronate (SH)
Trial: 9216117
Drug: fenofibrate 100
RxNorm normalized name: fenofibrate 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: fenofibrate 100 mg tid
Trial: 9216117
Drug: gemfibrozil 600
RxNorm normalized name: gemfibrozil 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: gemfibrozil 600 mg bid
Trial: 3311548
Drug: Ibuprofen 400
RxNorm normalized name: ibuprofen 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen 400 mg plus Codeine 60 mg
Trial: 3311548
Drug: Ibuprofen 200
RxNorm normalized name: ibuprofen 200 MG
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen 200 mg plus Codeine 30 mg
Trial: 3311548
Drug: Codeine 60
RxNorm normalized name: codeine 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Codeine 60 mg alone
Trial: 28443698
Drug: Maternal nutritional
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maternal nutritional supplementation (MNS) 252 kcal/day daily up to 12 weeks postpartum and four breastfeeding education and support sessions
Trial: 21910898
Drug: 2 g
RxNorm normalized name: Molds 2 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g of plant sterol esters daily in liquid yoghurt for 24 months
Trial: 17058629
Drug: Ezetimibe 10
RxNorm normalized name: ezetimibe 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ezetimibe 10 mg added to ongoing statin therapy
Trial: 12965106
Drug: nateglinide 120
RxNorm normalized name: nateglinide 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nateglinide 120 mg
Trial: 10930201
Drug: Oral clonidine
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral clonidine premedication (5 microg x kg(‐1) 90 min before surgery)
Trial: 8737759
Drug: Nifedipine solution
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine solution administered locally to the stomach
Trial: 8737759
Drug: Nifedipine solution
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine solution administered locally to the small intestine
Trial: 8737759
Drug: Nifedipine solution
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine solution administered locally to the colon (two sites)
Trial: 8737759
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion of nifedipine
Trial: 20669317
Drug: Pramipexole ER
RxNorm normalized name: pramipexole Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pramipexole ER once daily
Trial: 20669317
Drug: Pramipexole IR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pramipexole IR three times daily
Trial: 17432541
Drug: Application of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Application of antioxidant and mitochondrial stimulating cream and oral administration of antioxidants and phenylalanine
Trial: 17432541
Drug: Application of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Application of antioxidant and mitochondrial stimulating cream
Trial: 17432541
Drug: Placebo AF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo AF (application of a placebo cream and oral administration of antioxidants and phenylalanine)
Trial: 17432541
Drug: Without cream
RxNorm normalized name: threonine
DrugBank: Threonine (DB00156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Without cream AF (oral administration of antioxidants and phenylalanine)
Trial: 15710335
Drug: Conventional immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional immunotherapy (n=7)
Trial: 15710335
Drug: Short-term immunotherapy
RxNorm normalized name: hydrogen peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Short-term immunotherapy (n=7)
Trial: 11781125
Drug: Acupuncture (exact
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture (exact dosage and duration not specified)
Trial: 7554180
Drug: STAR (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: STAR (10 mg given intravenously over 30 minutes)
Trial: 7554180
Drug: STAR (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: STAR (20 mg given intravenously over 30 minutes)
Trial: 1983493
Drug: Postoperative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative treatment modalities including ventilation, deflation of the interponate, and special dietary plan
Trial: 20533765
Drug: Valacyclovir 250
RxNorm normalized name: valacyclovir 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valacyclovir 250 mg
Trial: 25147236
Drug: Valacyclovir 1000
RxNorm normalized name: valacyclovir 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valacyclovir 1000 mg
Trial: 19122337
Drug: Pranlukast 225
RxNorm normalized name: pranlukast
DrugBank: Pranlukast (DB01411)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Pranlukast 225 mg single dose
Trial: 19122337
Drug: Clarithromycin 200
RxNorm normalized name: Clarithromycin
DrugBank: Clarithromycin (DB01211)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clarithromycin 200 mg twice daily for 7 days + Pranlukast 225 mg single dose on day 7
Trial: 16618015
Drug: PRO 160/120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PRO 160/120 (2 x 1 capsule/d)
Trial: 16618015
Drug: Tamsulosin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamsulosin (1 x 0.4 mg/d)
Trial: 15105283
Drug: B9340 (bradykinin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: B9340 (bradykinin receptor antagonist)
Trial: 9699089
Drug: U40 regular
RxNorm normalized name: Insulina regular
DrugBank: Insulin human (DB00030)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: U40 regular insulin
Trial: 9699089
Drug: U100 regular
RxNorm normalized name: Insulina regular
DrugBank: Insulin human (DB00030)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: U100 regular insulin at 8 degrees C
Trial: 9699089
Drug: U100 regular
RxNorm normalized name: Insulina regular
DrugBank: Insulin human (DB00030)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: U100 regular insulin at 37 degrees C
Trial: 2689469
Drug: Verapamil-SR 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil-SR 60 mg
Trial: 2689469
Drug: Verapamil-SR 120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil-SR 120 mg
Trial: 8134676
Drug: Propofol (1%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (1% infusion at 6 mg/kg/h for 10 minutes, then 3 mg/kg/h)
Trial: 8134676
Drug: Midazolam (0.3%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (0.3% infusion with initial bolus of 0.06 mg/kg and infusion at 0.05 mg/kg/h)
Trial: 30444838
Drug: Intensive treatment
RxNorm normalized name: Head & Shoulders Intensive Treatment
DrugBank: Selenium Sulfide (DB00971)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive treatment (target SBP < 120 mmHg)
Trial: 30444838
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment (target SBP between 135 and 139 mmHg)
Trial: 24125483
Drug: Spironolactone 50
RxNorm normalized name: spironolactone 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spironolactone 50 mg daily for 6 weeks
Trial: 19106380
Drug: NPH/Lente insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NPH/Lente insulin
Trial: 15133820
Drug: Naloxone (non-subtype-selective
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxone (non-subtype-selective opioid receptor antagonist)
Trial: 7667832
Drug: Low-dose estrogen
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose estrogen (0.625 mg conjugated estrogens)
Trial: 7667832
Drug: Oral contraceptives
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptives (30-50 micrograms ethinyl estradiol daily)
Trial: 7667832
Drug: High-dose estrogen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose estrogen (300 micrograms ethinyl estradiol daily)
Trial: 2654329
Drug: C +
RxNorm normalized name: Probiotic + Colostrum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: C + M (methotrexate 50 mg/m2 on days 1 and 15 plus cisplatin 80 mg/m2 on day 2 every 4 weeks)
Trial: 2654329
Drug: C (cisplatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: C (cisplatin 80 mg/m2 on day 1 every 4 weeks)
Trial: 28279941
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy + trastuzumab in HER2-positive cases
Trial: 28279941
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy + celecoxib in HER2-negative cases
Trial: 21671456
Drug: Nabiximols 10.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nabiximols 10.8 mg
Trial: 21671456
Drug: Nabiximols 21.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nabiximols 21.6 mg
Trial: 21671456
Drug: Nabiximols 43.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nabiximols 43.2 mg
Trial: 11480500
Drug: Dietary antioxidants
RxNorm normalized name: antioxidant 119
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietary antioxidants (400 IU vitamin E/500 mg vitamin C)
Trial: 8049437
Drug: Standard or
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard or high-dose Ara-C together with daunorubicin and etoposide as induction chemotherapy
Trial: 3288477
Drug: L-dopa (as
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-dopa (as Sinemet)
Trial: 30131049
Drug: Treatment irrespective
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment irrespective of salt sensitivity and dosing regimen
Trial: 27428108
Drug: Complementary Therapies
RxNorm normalized name: Theraplex Eczema Therapy
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Complementary Therapies for Labour and Birth (CTLB) protocol, which includes acupressure, relaxation, visualisation, breathing, massage, yoga techniques, and facilitated partner support, attended a two-day antenatal education programme plus standard care.
Trial: 15679556
Drug: Supervised treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supervised treatment with sulfadoxine/pyrimethamine and artesunate
Trial: 15679556
Drug: Unsupervised treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unsupervised treatment with sulfadoxine/pyrimethamine and artesunate
Trial: 10589887
Drug: Daily trimethoprim-sulfamethoxazole
RxNorm normalized name: sulfamethoxazole / trimethoprim
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily trimethoprim-sulfamethoxazole (160 mg/800 mg)
Trial: 10589887
Drug: Thrice-weekly trimethoprim-sulfamethoxazole
RxNorm normalized name: sulfamethoxazole / trimethoprim
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrice-weekly trimethoprim-sulfamethoxazole (160 mg/800 mg)
Trial: 7852106
Drug: Twice-daily radiation
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Twice-daily radiation therapy (RT) at 1.2 Gy BID (64.8 Gy, 72.0 Gy, 76.8 Gy, 81.6 Gy)
Trial: 2045613
Drug: Atropine (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atropine (4 mg/ml) inhaled for 5 minutes
Trial: 2045613
Drug: Fenoterol (0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenoterol (0.4 mg/ml) inhaled for 5 minutes
Trial: 2045613
Drug: Aminophylline (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aminophylline (250 mg) intravenous injection
Trial: 21646287
Drug: Phlebotomy therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phlebotomy therapy
Trial: 6173993
Drug: Low-dose chloroquine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose chloroquine treatment
Trial: 31953634
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg pantoprazole per day for 3 months
Trial: 31953634
Drug: No PPI
RxNorm normalized name: PPI-1040
DrugBank: PPI-1040 (DB17620)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No PPI therapy
Trial: 23767862
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg of herbal blend twice daily
Trial: 20730056
Drug: Milk fortified
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milk fortified with 2.4 g/day of prebiotic oligosaccharide and 1.9x10(7) c.f.u/day of probiotic Bifidobacterium lactis HN019
Trial: 3786334
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg nasal nicotine solution (NNS)
Trial: 3786334
Drug: 0.15 mg
RxNorm normalized name: iodine 0.15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.15 mg nasal nicotine solution (NNS)
Trial: 3786334
Drug: 2.5 mg
RxNorm normalized name: biotin 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg mecamylamine
Trial: 3786334
Drug: Repeated dosing
RxNorm normalized name: eicosyl povidone (2 eicosyl branches-repeat)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repeated dosing with 2 mg NNS hourly for six hours
Trial: 21987535
Drug: Aliskiren 150
RxNorm normalized name: aliskiren 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aliskiren 150 mg/d for 7 days (aliskiren group, n = 10)
Trial: 16293536
Drug: Single concentration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single concentration methacholine inhalation provocation test (SCIPT) with doses of 0.03-1.8 mg (maximal cumulated dose 3.6 mg)
Trial: 16293536
Drug: Standard dosimeter
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard dosimeter method (SDM) with doses of 0.002-1.8 mg (maximal cumulative dose 3.5 mg)
Trial: 9873842
Drug: Home treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home treatment not available, less treatment in general
Trial: 8721461
Drug: Heparin-coated circuits
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin-coated circuits (HC group, n = 9)
Trial: 8721461
Drug: Heparin-coated circuits
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin-coated circuits (HC group)
Trial: 1824527
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg of nifedipine
Trial: 11806863
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg of propranolol
Trial: 1824527
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg of nifedipine and 40 mg of propranolol
Trial: 6339379
Drug: Oral killed
RxNorm normalized name: Hongo Killer
DrugBank: Undecylenic acid (DB11117)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral killed polyvalent bacterial vaccine (3 courses over 2 months, each course containing 10^10 Haemophilus influenzae and 7 x 10^9 Staphylococcus aureus organisms)
Trial: 6339379
Drug: Oral killed
RxNorm normalized name: Hongo Killer
DrugBank: Undecylenic acid (DB11117)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral killed polyvalent bacterial vaccine
Trial: 30565181
Drug: Metformin hydrochloride
RxNorm normalized name: Metformin Hydrochloride
DrugBank: Metformin (DB00331)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Metformin hydrochloride oral solution (500 mg/5 mL)
Trial: 30565181
Drug: Metformin hydrochloride
RxNorm normalized name: Metformin Hydrochloride
DrugBank: Metformin (DB00331)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Metformin hydrochloride tablets (500 mg)
Trial: 28629886
Drug: Mindfulness and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mindfulness and Self‐Compassion training program (2.5 hours/week for 8 weeks, 75% attendance, 45 minutes daily practice)
Trial: 18977579
Drug: Oxytocin 5IU
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxytocin 5IU bolus and placebo infusion
Trial: 18977579
Drug: Oxytocin 5IU
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxytocin 5IU bolus and oxytocin 30IU infusion
Trial: 18021388
Drug: Anti-GLURP-IgG antibodies
RxNorm normalized name: Anti-VEGF monoclonal antibody
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Anti-GLURP-IgG antibodies
Trial: 11993625
Drug: Regular carbohydrate‐electrolyte
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular carbohydrate‐electrolyte beverage (6.8% CHO, 18.7 mmol/L Na, 3.0 mmol/L K, 1,130 kJ/L)
Trial: 11993625
Drug: Low kilojoule
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low kilojoule electrolyte beverage (1% CHO, 18.7 mmol/L Na, 3.0 mmol/L K, 170 kJ/L)
Trial: 1679668
Drug: Roxatidine 150
RxNorm normalized name: roxatidine 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Roxatidine 150 mg nocte
Trial: 6352883
Drug: Intensive conventional
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive conventional therapy (three or four daily injections of insulin)
Trial: 29572761
Drug: Weekly administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Weekly administration of paclitaxel and carboplatin (W‐TC)
Trial: 27456885
Drug: PLISSIT model
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PLISSIT model based sexual counseling (4 weekly sessions, 90-120 min each)
Trial: 24131282
Drug: BG-12 240
RxNorm normalized name: isopropyl alcohol
DrugBank: Isopropyl alcohol (DB02325)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BG-12 240 mg three times daily
Trial: 15861940
Drug: Closed wound
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Closed wound group (wide resection of skin and subcutaneous tissue, followed by primary closure).
Trial: 15861940
Drug: Wide excision
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wide excision group (wide resection of skin and subcutaneous tissue, wounds left opened for secondary intention healing).